Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities
Although nonalcoholic fatty liver disease (NAFLD) is associated with obesity, it can also occur in lean and metabolically normal individuals. Our aim was to determine the effect of different combinations of abdominal adiposity and overall adiposity on the mortality of NAFLD. The Third National Healt...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1534 |
id |
doaj-93d73d367a8c4d48b2780ee4cbb5d1aa |
---|---|
record_format |
Article |
spelling |
doaj-93d73d367a8c4d48b2780ee4cbb5d1aa2020-11-25T03:12:26ZengWileyHepatology Communications2471-254X2020-08-01481136114810.1002/hep4.1534Mortality of NAFLD According to the Body Composition and Presence of Metabolic AbnormalitiesPegah Golabi0James M. Paik1Tamoore Arshad2Youssef Younossi3Alita Mishra4Zobair M. Younossi5Betty and Guy Beatty Center for Integrated Research, Inova Health System Inova Health System Falls Church VABetty and Guy Beatty Center for Integrated Research, Inova Health System Inova Health System Falls Church VACenter For Liver Diseases Department of Medicine Inova Fairfax Medical Campus Falls Church VACenter for Outcomes Research in Liver Diseases Washington DCCenter For Liver Diseases Department of Medicine Inova Fairfax Medical Campus Falls Church VABetty and Guy Beatty Center for Integrated Research, Inova Health System Inova Health System Falls Church VAAlthough nonalcoholic fatty liver disease (NAFLD) is associated with obesity, it can also occur in lean and metabolically normal individuals. Our aim was to determine the effect of different combinations of abdominal adiposity and overall adiposity on the mortality of NAFLD. The Third National Health and Nutrition Examination Survey with mortality data from the National Death Index were used. NAFLD was defined as steatosis without other liver diseases. Body composition was categorized according to waist circumference (WC) and body mass index (BMI). Obesity pattern was defined according to BMI (lean, overweight, and obese) and WC (normal and obese) using accepted definitions. The “metabolically abnormal” group had visceral obesity, insulin resistance, type 2 diabetes, hypertension, or hyperlipidemia. Of the 9,341 study individuals (47.9% male; 76.8% white), NAFLD was present in 3,140 (33.6%), of whom 0.6% had lean BMI and normal WC, and 1.7% had lean BMI and obese WC. The prevalence of metabolically normal NAFLD was 3.26% (95% confidence interval [CI]: 2.62%‐3.90%), with most of these subjects having lean BMI (79.2%). During an average follow‐up of 22.4 years, 24.1% of the subjects died from all causes. Among these deceased individuals, 41.7% had NAFLD at baseline. Causes of death were cardiovascular disease (24.8%), cancer‐related (24.3%), type 2 diabetes–related (4.4%), and liver‐related (1.7%). Individuals with NAFLD who were lean by BMI but obese by WC had higher risk of all‐cause mortality. Individuals with NAFLD with normal BMI but obese WC had a higher risk of cardiovascular mortality (hazard ratio 2.63 [95% CI: 1.15‐6.01]) as compared with overweight (by BMI) NAFLD with normal WC. Conclusion: The risk of mortality in NAFLD can be affected by the presence of visceral obesity, especially in the lean BMI group. These data have important management implications for patients with NAFLD.https://doi.org/10.1002/hep4.1534 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Pegah Golabi James M. Paik Tamoore Arshad Youssef Younossi Alita Mishra Zobair M. Younossi |
spellingShingle |
Pegah Golabi James M. Paik Tamoore Arshad Youssef Younossi Alita Mishra Zobair M. Younossi Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities Hepatology Communications |
author_facet |
Pegah Golabi James M. Paik Tamoore Arshad Youssef Younossi Alita Mishra Zobair M. Younossi |
author_sort |
Pegah Golabi |
title |
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities |
title_short |
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities |
title_full |
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities |
title_fullStr |
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities |
title_full_unstemmed |
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities |
title_sort |
mortality of nafld according to the body composition and presence of metabolic abnormalities |
publisher |
Wiley |
series |
Hepatology Communications |
issn |
2471-254X |
publishDate |
2020-08-01 |
description |
Although nonalcoholic fatty liver disease (NAFLD) is associated with obesity, it can also occur in lean and metabolically normal individuals. Our aim was to determine the effect of different combinations of abdominal adiposity and overall adiposity on the mortality of NAFLD. The Third National Health and Nutrition Examination Survey with mortality data from the National Death Index were used. NAFLD was defined as steatosis without other liver diseases. Body composition was categorized according to waist circumference (WC) and body mass index (BMI). Obesity pattern was defined according to BMI (lean, overweight, and obese) and WC (normal and obese) using accepted definitions. The “metabolically abnormal” group had visceral obesity, insulin resistance, type 2 diabetes, hypertension, or hyperlipidemia. Of the 9,341 study individuals (47.9% male; 76.8% white), NAFLD was present in 3,140 (33.6%), of whom 0.6% had lean BMI and normal WC, and 1.7% had lean BMI and obese WC. The prevalence of metabolically normal NAFLD was 3.26% (95% confidence interval [CI]: 2.62%‐3.90%), with most of these subjects having lean BMI (79.2%). During an average follow‐up of 22.4 years, 24.1% of the subjects died from all causes. Among these deceased individuals, 41.7% had NAFLD at baseline. Causes of death were cardiovascular disease (24.8%), cancer‐related (24.3%), type 2 diabetes–related (4.4%), and liver‐related (1.7%). Individuals with NAFLD who were lean by BMI but obese by WC had higher risk of all‐cause mortality. Individuals with NAFLD with normal BMI but obese WC had a higher risk of cardiovascular mortality (hazard ratio 2.63 [95% CI: 1.15‐6.01]) as compared with overweight (by BMI) NAFLD with normal WC. Conclusion: The risk of mortality in NAFLD can be affected by the presence of visceral obesity, especially in the lean BMI group. These data have important management implications for patients with NAFLD. |
url |
https://doi.org/10.1002/hep4.1534 |
work_keys_str_mv |
AT pegahgolabi mortalityofnafldaccordingtothebodycompositionandpresenceofmetabolicabnormalities AT jamesmpaik mortalityofnafldaccordingtothebodycompositionandpresenceofmetabolicabnormalities AT tamoorearshad mortalityofnafldaccordingtothebodycompositionandpresenceofmetabolicabnormalities AT youssefyounossi mortalityofnafldaccordingtothebodycompositionandpresenceofmetabolicabnormalities AT alitamishra mortalityofnafldaccordingtothebodycompositionandpresenceofmetabolicabnormalities AT zobairmyounossi mortalityofnafldaccordingtothebodycompositionandpresenceofmetabolicabnormalities |
_version_ |
1724650377918283776 |